Class Action Off-Label Drug Lawsuit Dismissed
A U.S. District Court judge sitting in Los Angeles dismissed an off-label drug promotion multi-district litigation on Dec. 17, 2008. The suit claimed that Amgen Inc., Da Vita Inc. and Fresenius Medical Care Holdings Inc.
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.